Active Monitoring Promising for Women with Low-Risk Ductal Carcinoma In Situ By Ogkologos - January 8, 2025 777 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COMET study Source RELATED ARTICLESMORE FROM AUTHOR EMA Adopts a Positive Opinion for a New Route of Administration Together with a New Pharmaceutical Form and a New Strength for Isatuximab National Study Examines Genetic Testing to Inform Follow-up Care for Cancer Survivors Taletrectinib Demonstrates Durable Long-Term Efficacy in Both TKI-naïve and Crizotinib-pretreated Patients with Advanced ROS1-positive NSCLC MOST POPULAR Is CBD Safe for People With Cancer? September 22, 2020 Smoking addiction killed my grandfather – now it’s up to the... December 29, 2022 Adjuvant Therapy with Oxaliplatin Added to Fluoropyrimidine Improves Survival in Patients... January 15, 2021 Long-Term Benefit of Sotorasib in Patients with Pretreated KRASG12C-Mutated NSCLC May 15, 2023 Load more HOT NEWS 3D-Printed Surgical Guides Are Helping Surgeons Save More Breast Tissue While... FDA Approves Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma Can Getting a “Base Tan” Protect You From Sunburn and Skin... To Improve Immunotherapy, Researchers Look at Limiting Cancer’s Access to Sugar...
